Literature DB >> 6309842

Glucagon receptors on isolated hepatocytes and hepatocyte membrane vesicles. Discrete populations with ligand- and environment-dependent affinities.

V Bonnevie-Nielsen, H S Tager.   

Abstract

Analysis of glucagon and deshistidine glucagon binding to isolated canine hepatocytes and to hepatocyte membrane vesicles (formed by budding of hepatocytes in hypotonic medium) reveals two separate populations of hormone binding sites. Mathematical modeling further shows that the high affinity population represents 1% of the total in all four cases. Although calculated dissociation constants for hormone binding range from 0.2 to 400 nM, whether considering glucagon or deshistidine glucagon binding, or binding to the high affinity or low affinity receptor populations, receptor affinity increases 2- to 100-fold in the environment of the membrane vesicle; concomitant with this alteration in receptor affinity, receptor selectivity for the structure of the native hormone decreases 1.5- to 40-fold in hepatocyte-derived vesicles. Consideration of receptor affinity in relation to receptor number suggests that hepatocyte glucagon binding is distributed about equally between high and low affinity receptor populations at typical portal hormone levels. Nevertheless, consideration of receptor binding in relation to biological activity suggests that the activity of glucagon in inhibiting carbohydrate flux into glycogen is attributable to occupancy of the high affinity receptor population.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309842

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Identification of distinct receptor complexes that account for high-and low-affinity glucagon binding to hepatic plasma membranes.

Authors:  J C Mason; H S Tager
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Mechanism of action of des-His1-[Glu9]glucagon amide, a peptide antagonist of the glucagon receptor system.

Authors:  S R Post; P G Rubinstein; H S Tager
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

Review 3.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

4.  Hepatic glucagon metabolism. Correlation of hormone processing by isolated canine hepatocytes with glucagon metabolism in man and in the dog.

Authors:  W A Hagopian; H S Tager
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

5.  Twenty-eighth annual meeting of the British Association for Cancer Research (in conjunction with the second annual meeting of the Association of Cancer Physicians). April 6-8, 1987, Newcastle-upon-Tyne, UK. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

Review 6.  PTH1R Actions on Bone Using the cAMP/Protein Kinase A Pathway.

Authors:  T John Martin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-19       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.